David Hale joins the Guerbet Executive Committee as Chief Commercial Officer, Diagnostic Imaging
Villepinte (France), February 19, 2018 (08:00 CET) – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, has announced the appointment of David Hale as Chief Commercial Officer Diagnostic Imaging
“We are delighted to welcome David as a new member of our Executive Committee. His solid international experience, leadership and knowledge of the commercial challenges facing the radiology industry, in particular in the fields of digital solutions, technical services and equipment, will be invaluable assets as we continue our growth in diagnostic imaging by developing a comprehensive range addressing radiologists’ needs,” said Yves L’Epine, Chief Executive Officer, Guerbet.
David is joining Guerbet after 17 years spent with General Electric Healthcare where he was President of Enterprise Imaging and Care Area Software Solutions, having also held various sales, marketing and development positions both regionally and globally.
David Hale has dual American and French nationality and holds a degree in Industrial and Systems Engineering from the Georgia Institute of Technology (USA) and an MBA from the International Institute for Management Development business school (Lausanne, Switzerland).
Diagnostic imaging is Guerbet’s core business, an activity that covers all of the products, services and solutions used in this specialty field, from CT/cath lab and MRI contrast media to injectors, injection medical devices, software and service activities. Guerbet has already built a strong position for itself in this segment with leading brands.